Penny. Believe the inhaler trial is the P2b/3 trial and may or may not be recruiting yet. Looking at the clinical trials update they haven't stated active and recruiting ...probably needed the $ they recently received.
The IV trial is a P 2.... but supported by the compassionate use data ...may / will be enough for approval for wider use if the data is as good as we hope . Just my take Kiwi
Market Data 
Markets 
AI
